Longboard Pharmaceuticals, Inc. (LBPH)
Dec 2, 2024 - LBPH was delisted (reason: acquired by Lundbeck)
59.98
0.00 (0.00%)
Inactive · Last trade price
on Nov 29, 2024
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for LBPH stock had an average target of 52.29, with a low estimate of 32 and a high estimate of 60.
Analyst Consensus: Buy
* Price targets were last updated on Oct 15, 2024.
Analyst Ratings
The average analyst rating for LBPH stock from 8 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 2 | 2 |
| Buy | 4 | 4 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $80 → $60 | Strong Buy → Hold | Downgrades | $80 → $60 | +0.03% | Oct 15, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $60 | Strong Buy → Hold | Downgrades | $60 | +0.03% | Oct 15, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $45 → $60 | Strong Buy → Hold | Downgrades | $45 → $60 | +0.03% | Oct 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +33.38% | Sep 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.27
from -2.39
EPS Next Year
-2.88
from -2.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 10.5M | |||
| Avg | n/a | n/a | 1.7M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.18 | -2.63 | -3.01 | |||
| Avg | -2.27 | -2.88 | -3.21 | |||
| Low | -2.23 | -3.06 | -3.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.